Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Cash from Investing Activities: 2011-2025

Historic Cash from Investing Activities for Niagen Bioscience (NAGE) over the last 12 years, with Sep 2025 value amounting to -$24,000.

  • Niagen Bioscience's Cash from Investing Activities fell 14.29% to -$24,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$260,000, marking a year-over-year decrease of 173.68%. This contributed to the annual value of -$143,000 for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q3 2025, Niagen Bioscience's Cash from Investing Activities is -$24,000, which was up 82.22% from -$135,000 recorded in Q2 2025.
  • In the past 5 years, Niagen Bioscience's Cash from Investing Activities registered a high of -$2,000 during Q4 2021, and its lowest value of -$265,000 during Q2 2021.
  • Over the past 3 years, Niagen Bioscience's median Cash from Investing Activities value was -$26,000 (recorded in 2023), while the average stood at -$43,364.
  • In the last 5 years, Niagen Bioscience's Cash from Investing Activities slumped by 8,500.00% in 2022 and then spiked by 94.12% in 2023.
  • Over the past 5 years, Niagen Bioscience's Cash from Investing Activities (Quarterly) stood at -$2,000 in 2021, then plummeted by 8,500.00% to -$172,000 in 2022, then skyrocketed by 87.79% to -$21,000 in 2023, then slumped by 228.57% to -$69,000 in 2024, then declined by 14.29% to -$24,000 in 2025.
  • Its Cash from Investing Activities stands at -$24,000 for Q3 2025, versus -$135,000 for Q2 2025 and -$32,000 for Q1 2025.